Table 4

Distribution of children by occurrence of congenital toxoplasmosis according to maternal treatment with spiramycin during pregnancy (2012, Goiânia/ GO, Brazil)
Aspects Maternal treatment p OR (IC)
Treated Untreated
N % N %
1) Clinical type
 Mild form birth 57 81.4 33 39.3 0.148
Severe disease at birth 13 18.6 51 60.7 <0.001 (0.070-0.311)
  Total 70 100.0 84 100.0
2) Congenital toxoplasmosis
 Without toxoplasmosis 50 41.7 31 27.0 0.018 0.517
 Congenital toxoplasmosis 70 58.3 84 73.0 (0.298-0.895)
  Total 120 100.0 115 100.0
3) Severe disease at birth
 Intracranial calcification 5 38.5 6 11.8
 Ocular 2 15.4 8 15.7
 Neuro-optical 5 38.5 31 60.8 0.030 0.377
 Systemica 1 7.7 6 11.8 (0.185-0.765)
  Total 13 100.0 51 100.0
4) Mild form birth
 Assimptomatic 32 56.1 19 57.6
 Meningitis 20 35.1 12 36.4 0.321 1.222
 Nodal 1 1.8 2 6.1 (0.678-2.201)
 Auditory 4 7.0 0 0.0
  Total 57 100.0 33 100.0

Test: x2.

Avelino et al.

Avelino et al. BMC Infectious Diseases 2014 14:33   doi:10.1186/1471-2334-14-33

Open Data